Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-014418
Filing Date
2019-05-22
Accepted
2019-05-22 21:02:56
Documents
1
Period of Report
2019-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6937
  Complete submission text file 0000899243-19-014418.txt   9255
Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences III, L.P. (Reporting) CIK: 0001597143 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1214
Type: 4 | Act: 34 | File No.: 001-38537 | Film No.: 19847652

Mailing Address C/O CLARUS VENTURES 101 MAIN STREET, SUITE 1210 CAMBRIDGE MA 02142
Business Address C/O CLARUS VENTURES 101 MAIN STREET, SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Ventures III GP, L.P. (Reporting) CIK: 0001620148 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38537 | Film No.: 19847653

Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Issuer) CIK: 0001681087 (see all company filings)

EIN.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)